Home›People›Gerald Baty
Gerald Baty

Gerald Baty

Executive officer at Stitchlock. Also a director at Seraxis.

ExecutiveDirectorRoles at 2 startups
Updated Nov 9, 2026·Latest SEC filing Sep 24, 2026·Suggest an edit

About Gerald Baty

Gerald Baty is an executive officer at Stitchlock.

Form D filings also name Gerald Baty as a director at Seraxis.

Gerald Baty first appears on SEC filings in 2023.

Experience

This experience comes from Gerald Baty's profile and from SEC filings. For roles taken from filings, the years are when the filings name Gerald Baty in the role, so the role may have started earlier or lasted longer.

Stitchlock, Inc. Current
Founder, President and CEO
2022 – Present · Webster, TX
Develops knot-free wound closure devices for surgeons.
Seraxis Holdings, Inc. Current
Chairman Of The Board Of Directors, Compensation Committee Member
2021 – Present · Germantown, MD
Develops cell replacement therapy for people with insulin-dependent diabetes.
Newport LLC Current
Partner
2020 – Present
Emerald - This is the Way to Fly Current
Founder
2020 – Present
Houston Symphony Current
Audit Committee Member
2020 – Present
Lighthouse For Students Current
Outside Director - Board Treasurer
2020 – Present
SafeTech-USA
Chief Executive Officer
2015 – 2020
GB Consulting & Strategy Development
Managing Director & Founder
2014 – 2015
AxioMed Spine Corporation
Chief Financial Officer
2008 – 2014
Mt. Cook
Chief Financial Officer
2007 – 2008
Transave Inc.
VP Finance
2003 – 2007
Genzyme
Dir of Finance
2000 – 2002
Texas Biotechnology
Controller
1995 – 2000
Kenneth Leventhal & Co
Audit Staff
1994 – 1995

Key Colleagues at Startups

The people Gerald Baty works with at each company, as listed on that company's latest Form D.

Seraxis Holdings, Inc. · Form D, Sep 24, 2026
William Rust
William Rust
Chief Executive Officer, Founder, Director of Board
Carole Welsch
Carole Welsch
Chief Operating Officer, Co-Founder

Sources

  1. SECSeraxis Holdings, Inc. Form D, filed Sep 24, 2026
  2. SECStitchlock, Inc. Form D, filed Jun 26, 2026